The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Patents, Royalties, Other Intellectual Property - US2021060902
Correlation of cancer testis antigen expression with high type-I interferon signal and prognosis in small bowel neuroendocrine tumors.
 
Reed I. Ayabe
No Relationships to Disclose
 
Yongwoo David Seo
No Relationships to Disclose
 
Brenda Melendez
No Relationships to Disclose
 
Rossana Lazcano Segura
No Relationships to Disclose
 
Brittany C. Fields
No Relationships to Disclose
 
Khalida M. Wani
No Relationships to Disclose
 
Sarah Johnson
No Relationships to Disclose
 
Russell Witt
No Relationships to Disclose
 
Manoj Chelvanambi
No Relationships to Disclose
 
Courtney Hudgens
No Relationships to Disclose
 
Sharia D. Hernandez
No Relationships to Disclose
 
Nadim J. Ajami
Research Funding - SNIPR Biome
 
Jennifer Ann Wargo
Stock and Other Ownership Interests - Micronoma
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Genentech; GlaxoSmithKline; Illumina; Merck; Novartis
Research Funding - Bristol-Myers Squibb; Genentech; GlaxoSmithKline; Novartis
Patents, Royalties, Other Intellectual Property - Patent submitted regarding role of microbiome in response to immune checkpoint blockade
 
Alexander J. Lazar
Leadership - Archer; Iterion Therapeutics; Nucleai
Honoraria - Bristol-Myers Squibb; Genentech/Roche; Janssen Oncology; Novartis
Research Funding - AstraZeneca; MedImmune; Novartis; Roche
 
Daniel M. Halperin
Consulting or Advisory Role - Amryt Pharma; Camurus; Chimeric Therapeutics; Crinetics Pharmaceuticals; Harbour BioMed; Ipsen; Isotopen Technologien; Novartis; Progenics; Radiomedix; Tersera
Research Funding - Advanced Accelerator Applications (Inst); Camurus (Inst); Genentech/Roche (Inst); Isotopen Technologien (Inst); RayzeBio (Inst); Tarveda Therapeutics (Inst); Thermo Fisher Scientific (Inst)
 
Jeannelyn Estrella
No Relationships to Disclose
 
Jess Maxwell
No Relationships to Disclose